Pluristem Therapeutics Sees Positive Result for Stem Cell Therapy

Published: Sep 14, 2010

TEL AVIV, Sept 14 (Reuters) - Pluristem Therapeutics (PSTI.O) said early clinical trials show its placenta-derived cell therapy is safe and improves quality of life in patients with degenerative disorder peripheral artery disease (PAD).

Back to news